CSPC ZhongQi Pharmaceutical Technology Co., Ltd. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
- Minor: Research of Ammoxetine Hydrochloride Enteric-coated Tablets · Depression Completed without a posted recruiting period
- Notable: SYH2082 Injection in Healthy Participants Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-11-03 | NCT07911579 A Study of SYH2051 in Combination With Irinotecan Hydrochloride Liposome Injection in… | Phase 1/2 | Not Yet Recruiting |
Active trials by phase
| Phase 1 | 10 | |
| Phase 1/2 | 5 | |
| Phase 2 | 9 | |
| Phase 2/3 | 3 | |
| Phase 3 | 10 |
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials, top 10 of 18
Breast Cancer (8) · HER2-Positive Cancer (3) · COPD (2) · Gastric Cancer (2) · Acute Myeloid Leukemia (AML) (1) · Asthma (1) · Colorectal Cancer (1) · Esophageal Cancer (1) · Hypertension (1) · Leukemia (1)
Get alerts when CSPC ZhongQi Pharmaceutical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.